drugset / Trial / NCT03601260

The Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients

NCT03601260

Unknown 700 enrolled Hillel Yaffe Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to determine the percentage of cases of acute treatment with Allopurinol in gout patients who have been previously treated.

Timeline

Start
2018-08
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Allopurinol Small molecule 100 mg Oral
Subject Allopurinol Small molecule 300 mg Oral

Indications